Obeticholic Acid Among Chronic HBV Patients with Hepatic Steatosis : Clinical and Portal Doppler Outcomes

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
In this study, the investigators aimed to evaluate the hepatoprotective effect of OCA against HBV-induced liver injury by comparing patients demographic , laboratory date ( liver function , viremia ) , degree of hepatic steatosis and fibrosis and portal doppler at the beginning and after six months .
Epistemonikos ID: 5703b7f835c7065dea5bfafb844131214b06a7f6
First added on: Apr 17, 2025